Riskpilot← Back to searchSign inGet full accessEDWARDS LIFESCIENCES A/S
A/SActiveCVR 25045270Ørestads Boulevard 73Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 19997 employees
Revenue 2024
DKK 24,7M
+31% vs 2023
EBITDA margin
43.6%
+153% vs 2023
Equity ratio
65.7%
Financial strength
Net profit 2024
DKK 8,3M
+183% vs 2023
| Revenue | DKK 24,7M | +31% |
| EBITDA | DKK 10,8M | +153% |
| Net profit | DKK 8,3M | +183% |
| Total assets | DKK 45M | +44% |
| Equity | DKK 29,6M | +39% |
| Employees | 7 | — |
Legal name
EDWARDS LIFESCIENCES A/S
CVR number
25045270
Legal form
Aktieselskab
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
15. november 1999
Share capital
DKK 500.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem eller af en direktør.
Company purpose
Selskabets formål er at drive handel med medicinsk og farmaceutiske udstyr til brug inden for medicinalindustrien, at besidde og eje kapitalandele i danske eller udenlandske selskaber og anden dermed i forbindelse stående virksomhed.
Address
Ørestads Boulevard 73
Phone
+4570223438
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12.028 | 14.840 | 15.826 | 18.841 | 24.747 |
| Staff expenses | -7.650 | -9.486 | -10.501 | -14.588 | -13.969 |
| EBITDA | 4.378 | 5.355 | 5.326 | 4.252 | 10.778 |
| Depreciation & amort. | -25 | -21 | -22 | -20 | -19 |
| EBIT | 4.353 | 5.334 | 5.303 | 4.233 | 10.759 |
| Net financials | -204 | -138 | -136 | -228 | 6 |
| Profit before tax | 4.149 | 5.196 | 5.168 | 4.004 | 10.765 |
| Tax | 986 | 1.217 | 1.163 | 1.091 | 2.507 |
| Net profit | 3.163 | 3.979 | 4.005 | 2.913 | 8.257 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23.781 | 41.226 | 29.047 | 31.276 | 45.013 |
| Equity | 10.424 | 14.398 | 18.403 | 21.314 | 29.571 |
| Long-term debt | 843 | 0 | 0 | 0 | 0 |
| Short-term debt | 12.515 | 26.829 | 10.615 | 9.931 | 15.400 |
| Total debt | 13.357 | 26.829 | 10.615 | 9.931 | 15.400 |
EBITDA margin
43.6%
This company
15.8%
Market median
+176% vs market
20202024
Equity ratio
65.7%
This company
38.2%
Market median
+72% vs market
20202024
Return on equity
27.9%
This company
18.4%
Market median
+52% vs market
20202024
Net profit margin
33.4%
This company
8.1%
Market median
+312% vs market
20202024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20202024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PL Chief Executive Officer | Chief Executive Officer | 2016 |
| Former (5) | ||
PB Chief Executive Officer | Chief Executive Officer | 2004 – 2012 |
AB Management | Management | 2000 – 2004 |
DR Chief Executive Officer | Chief Executive Officer | 2012 – 2012 |
JB Management | Management | 2012 – 2016 |
PA Management | Management | 1999 – 2000 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2018 | |
| Former (8) | ||
| Board of Directors | 1999 – 2000 | |
| Board of Directors | 2000 – 2007 | |
| Board of Directors | 2011 – 2018 | |
| Board of Directors | 2007 – 2024 | |
| Board of Directors | 2000 – 2011 | |
| Board of Directors | 2000 – 2004 | |
| Chairman | 1999 – 2000 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2023 | |
| Individual | 100% | 100% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EDWARDS LIFESCIENCES A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Patrick Bruno Noel Verguet | Chief Executive Officer | 0 companies |
| Andre-Michel Ballester | Management | 0 companies |
| David Ronald Jones | Chief Executive Officer | 0 companies |
| Jean-Francois Beyrath | Management | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Patrice Lucien Pascal Cappelle | Chief Executive Officer | 0 companies |
| Annemette Heller | Board of Directors | 0 companies |
| Raymond Lauret | Board of Directors | 0 companies |
| Denise Ellen Botticelli | Board of Directors | 0 companies |
| Robert William Armbruster Sellers | Board of Directors | 0 companies |
| Jay Philip Wertheim | Board of Directors | 0 companies |
| Andrew Michael Dahl | Board of Directors | 0 companies |
| Rene Delabre | Board of Directors | 0 companies |
| Kim Madsen | Chairman | 0 companies |
| Per Jonas Örtegren | Board of Directors | 0 companies |
| Linda Park | Board of Directors | 0 companies |